Document is current

Any future updates will be listed below

Correction: BCMA/GPRC5D bispecific CAR T-cell therapy for relapsed/refractory multiple myeloma with extramedullary disease: a single-center, single-arm, phase 1 trial

Crossref DOI link: https://doi.org/10.1186/s13045-025-01714-1

Published Online: 2025-06-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark